This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carrier of infectious disease
Z21_CARRIER_INFECTIOUS_DISEA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
880 |
4. Check minimum number of eventsNone |
880 |
5. Include endpointsNone |
880 |
6. Filter based on genotype QC (FinnGen only) |
880 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z2
Similar endpoints
↥List of similar endpoints to
Carrier of infectious disease
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to communicable diseases
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 880 | 566 | 314 |
| Unadjusted period prevalence (%) | 0.17 | 0.19 | 0.14 |
| Median age at first event (years) | 48.34 | 41.40 | 60.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 807
- Matched controls
- 8070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
7329.2
323.0
404
*
Z22.9
ICD-10 Finland
Carrier of infectious disease, unspecified
+∞
124.2
116
*
Z22.38
ICD-10 Finland
Carrier of other specified bacterium diseases
1190.0
109.1
104
*
Z22.30
ICD-10 Finland
Latent tuberculosis
+∞
91.4
86
*
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
+∞
86.0
81
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.9
69.0
191
349
J04AB02
ATC
rifampicin; systemic
34.7
56.3
73
23
Z22.8
ICD-10 Finland
Carrier of other infectious diseases
+∞
53.7
51
*
Z13.9
ICD-10 Finland
Special screening examination, unspecified
76.3
50.8
57
8
J01FF01
ATC
clindamycin; systemic
3.4
50.4
324
1330
B18.2
ICD-10 Finland
Chronic viral hepatitis C
25.4
49.8
70
30
J01MA12
ATC
levofloxacin; systemic
3.9
45.2
220
711
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
86.3
37.2
41
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
33.1
134
358
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
27.4
133
413
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
25.9
215
965
J01DB01
ATC
cefalexin; oral
2.7
25.9
692
5551
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
25.5
352
2052
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
11.0
24.1
46
44
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
23.2
144
535
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
23.0
253
1308
ZZA00
NOMESCO Finland
Split skin graft
7.9
22.5
52
70
J01MA02
ATC
ciprofloxacin; systemic
2.2
22.5
330
1947
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.0
21.9
50
66
H02AB06
ATC
prednisolone; systemic
2.1
21.2
383
2449
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
21.2
147
585
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
20.6
251
1351
Z72.2
ICD-10 Finland
Drug use
18.9
20.5
31
17
S97
ICPC
Chronic ulcer skin
4.9
20.5
69
151
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
20.3
136
529
N02AX02
ATC
tramadol; systemic, rectal
2.1
19.8
337
2085
A41.9
ICD-10 Finland
Sepsis, unspecified
5.8
19.1
55
101
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
19.0
127
490
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
18.9
130
509
A02BC02
ATC
pantoprazole; systemic
2.0
18.7
496
3617
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
21.4
18.7
27
13
C03CA01
ATC
furosemide; systemic
2.3
18.7
209
1072
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
18.6
178
845
N05BA04
ATC
oxazepam; oral
2.2
18.2
223
1190
N05CD07
ATC
temazepam; oral
3.0
18.2
111
402
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
17.9
175
835
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
4.4
17.9
67
164
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
97.2
17.6
19
*
A46
ICD-10 Finland
Erysipelas
2.8
17.5
123
489
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.1
17.2
42
62
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
17.0
91
302
Z11.2
ICD-10 Finland
Special screening examination for other bacterial diseases
+∞
16.7
16
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
16.2
136
599
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.0
16.0
36
47
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
15.9
118
485
N05BA01
ATC
diazepam; systemic, rectal
2.6
15.5
124
530
P01AB01
ATC
metronidazole; oral, rectal
1.9
15.5
327
2138
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.0
15.5
95
346
N02BE01
ATC
paracetamol; systemic, rectal
2.1
15.5
677
5726
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.2
220
1250
J01EA01
ATC
trimethoprim; systemic
2.0
15.0
219
1245
N02AA05
ATC
oxycodone; systemic
2.6
14.8
115
484
N30.0
ICD-10 Finland
Acute cystitis
2.4
14.8
133
607
N03AE01
ATC
clonazepam; systemic
3.6
14.8
68
201
N06AX11
ATC
mirtazapine; oral
1.9
14.8
258
1572
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
18.8
14.7
22
12
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.4
14.6
72
225
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
152.6
14.5
15
*
N06AB06
ATC
sertraline; oral
2.6
14.5
113
477
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.1
14.4
39
67
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.3
14.3
75
245
L04AX01
ATC
azathioprine; systemic
4.2
14.3
54
134
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
14.2
104
422
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
14.1
53
131
N05CF01
ATC
zopiclone; oral
1.9
14.0
245
1489
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.4
13.9
50
118
SPAT1262
SPAT
Handing over of treatment supplies
2.2
13.9
150
745
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
13.5
60
173
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
13.4
226
1350
S18
ICPC
Laceration/cut
1.8
13.3
319
2148
AA1AD
NOMESCO Finland
CT of head and brain
2.1
13.3
177
963
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
5.1
13.2
41
83
N05AH04
ATC
quetiapine; oral
2.1
13.1
161
846
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.0
13.1
27
31
J01XC01
ATC
fusidic acid; systemic
10.3
13.0
25
25
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
17.1
13.0
20
12
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.3
13.0
22
17
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
4.1
13.0
51
132
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
12.9
100
419
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.4
12.9
33
53
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
12.8
420
3110
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.3
12.8
47
114
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
12.6
266
1712
Z22.1
ICD-10 Finland
Carrier of other intestinal infectious diseases
+∞
12.5
12
*
Z41.8
ICD-10 Finland
Other procedures for purposes other than remedying health state
131.9
12.5
13
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
12.4
55
158
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
12.3
80
303
E0000UV
ATC
NA
1.8
12.2
316
2165
L03.9
ICD-10 Finland
Cellulitis, unspecified
6.0
12.2
33
57
S76
ICPC
Skin infection other
3.7
12.2
53
150
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
12.1
103
453
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.4
11.9
43
103
SPAT1260
SPAT
Consultation of another employee
2.1
11.8
154
829
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
11.8
73
268
F10.24
ICD-10 Finland
Alcohol depence active use
7.9
11.7
26
34
L04AA06
ATC
mycophenolic acid; systemic
7.0
11.7
28
41
SPAT1263
SPAT
Sampling
1.7
11.7
352
2516
ZX120
NOMESCO Finland
Intravenous
2.7
11.6
80
314
X58
ICD-10 Finland
Exposure to other specified factors
2.2
11.6
122
597
SPAT1229
SPAT
Assessment of need for aid
3.0
11.4
67
238
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
4.1
11.3
44
113
J01CA08
ATC
pivmecillinam; oral
1.7
11.3
326
2291
P19
ICPC
Drug abuse
9.1
11.3
23
26
NHQ40
NOMESCO Finland
Amputation of toe
9.1
11.3
23
26
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
11.3
74
282
J01CF05
ATC
flucloxacillin; systemic
3.9
11.2
46
124
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
11.2
71
265
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
11.2
49
140
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
11.2
121
599
N07BB01
ATC
disulfiram; oral
3.7
11.2
48
135
TK800
NOMESCO Finland
Hemodialysis
6.6
11.2
28
44
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
20.4
11.2
16
8
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
20.4
11.2
16
8
WX110
NOMESCO Finland
Local anesthesy
1.7
11.1
549
4486
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
7.2
11.1
26
37
V03AE01
ATC
polystyrene sulfonate; oral
8.7
11.1
23
27
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.0
11.1
64
225
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.1
11.1
34
69
A06AD11
ATC
lactulose; oral
2.3
11.0
107
504
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
11.0
76
298
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
11.0
353
2557
M79.6
ICD-10 Finland
Pain in limb
1.7
10.9
275
1855
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
10.9
67
245
N05AA02
ATC
levomepromazine; systemic
3.7
10.9
46
128
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
10.8
57
188
M86.6
ICD-10 Finland
Other chronic osteomyelitis
28.4
10.7
14
5
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
21.8
10.7
15
7
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
10.7
142
768
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.1
10.7
28
47
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
10.6
95
430
N03AX16
ATC
pregabalin; oral
1.9
10.6
181
1074
H02AB04
ATC
methylprednisolone; systemic
2.2
10.6
115
571
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
10.4
60
210
R53
ICD-10 Finland
Malaise and fatigue
1.9
10.4
171
1000
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
8.3
10.4
22
27
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.3
10.4
95
435
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
33.0
10.3
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
10.3
141
771
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
10.3
144
793
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.2
10.2
38
94
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.4
10.2
89
396
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.0
10.2
59
207
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.0
10.2
27
46
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
13.3
10.2
17
13
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.6
10.2
34
76
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
10.2
289
2009
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
10.1
114
575
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.2
10.0
26
43
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.3
10.0
36
87
J01DA01
ATC
[U] cefalexin; systemic
1.6
10.0
476
3796
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
9.8
57
201
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
9.8
89
405
UJF32
NOMESCO Finland
Coloscopy
1.8
9.8
190
1173
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.7
9.8
32
70
SPAT1254
SPAT
Administration of medicine
2.1
9.7
122
644
UKC02
NOMESCO Finland
Cystoscopy
2.1
9.7
115
589
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.6
9.7
42
120
B01AB05
ATC
enoxaparin; parenteral
1.8
9.6
209
1339
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
9.5
99
480
SPAT1211
SPAT
Application of soft bandage
2.4
9.5
80
352
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
9.5
283
1988
L28
ICPC
Limited function/disability (L)
2.2
9.5
105
524
SPAT1310
SPAT
Counselling related to known health issue
1.7
9.5
258
1767
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
5.4
9.4
27
51
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.8
9.3
19
22
SPAT1281
SPAT
Other administrative function
2.4
9.3
76
329
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
9.2
74
315
J01MA14
ATC
moxifloxacin; systemic
2.5
9.1
72
306
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.0
9.1
35
90
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
9.0
147
853
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.9
9.0
36
96
N06AB10
ATC
escitalopram; oral
1.8
9.0
174
1070
R33
ICD-10 Finland
Retention of urine
2.7
9.0
60
231
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
18.8
8.9
13
7
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.2
8.9
93
453
A02BC01
ATC
omeprazole; systemic
1.7
8.9
202
1307
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
8.9
52
185
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.2
8.8
26
51
R4180
NOMESCO Finland
Podiatric therapy
9.6
8.8
17
18
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
8.7
145
849
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
8.7
55
205
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
2.6
8.7
62
248
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
8.6
147
870
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
8.6
317
2339
R42
ICD-10 Finland
Dizziness and giddiness
1.8
8.6
150
894
R60.0
ICD-10 Finland
Localized oedema
2.3
8.5
81
378
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.8
8.5
35
96
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
8.5
151
900
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.4
8.5
29
67
N06AB04
ATC
citalopram; systemic
1.8
8.5
167
1033
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
8.5
75
337
P01BA02
ATC
hydroxychloroquine; oral
2.5
8.4
67
286
WX320
NOMESCO Finland
Spinalanesthesy
1.8
8.4
163
1004
J01XX08
ATC
linezolid; systemic
12.9
8.4
14
11
NGQ20
NOMESCO Finland
Amputation of lower leg
12.9
8.4
14
11
N05AH03
ATC
olanzapine; systemic
2.6
8.4
60
241
WX212
NOMESCO Finland
Femoral plexus blockade
6.3
8.4
21
34
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
8.3
70
308
H02AB07
ATC
prednisone; oral
2.0
8.3
105
552
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.8
8.3
53
200
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.3
170
1065
J01MA06
ATC
norfloxacin; oral
2.0
8.3
107
569
R11
ICD-10 Finland
Nausea and vomiting
2.4
8.3
71
313
Z00.0
ICD-10 Finland
General medical examination
1.8
8.3
146
871
N06AA09
ATC
amitriptyline; systemic
2.3
8.3
74
335
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
8.3
60
244
A28
ICPC
Limited function/disability NOS
2.2
8.2
88
433
WX730
NOMESCO Finland
Conventional respirator
5.5
8.2
23
43
127
Kela drug reimbursment
Transplant complication
6.1
8.2
21
35
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
8.1
63
267
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
9.0
8.1
16
18
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
8.0
122
690
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
8.0
61
255
L17
ICPC
Foot/toe symptom/complaint
1.7
7.9
177
1133
D07AB08
ATC
desonide; topical
2.1
7.9
88
439
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.0
7.9
30
77
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
8.6
7.8
16
19
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
7.8
50
189
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
7.8
85
421
Z71.8
ICD-10 Finland
Other specified counselling
1.7
7.8
182
1183
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
9.5
7.8
15
16
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.1
7.8
18
26
M54.5
ICD-10 Finland
Low back pain
1.6
7.8
247
1744
L04AA01
ATC
[U] ciclosporin; systemic
6.5
7.7
19
30
B17.1
ICD-10 Finland
Acute hepatitis C
45.4
7.7
9
*
A10BB12
ATC
glimepiride; oral
2.7
7.7
50
191
N05AX08
ATC
risperidone; systemic
2.3
7.7
68
307
R4110
NOMESCO Finland
Physiotherapy
1.7
7.7
182
1188
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
18.6
7.6
11
6
D07AC01
ATC
betamethasone; topical
1.6
7.6
236
1653
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.6
201
1349
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
12.0
7.6
13
11
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
25.3
7.6
10
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
7.5
90
465
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
7.5
51
198
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.2
7.5
17
24
Z94.0
ICD-10 Finland
Kidney transplant status
7.2
7.5
17
24
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
7.5
26
62
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
7.4
220
1520
A11CC03
ATC
alfacalcidol; systemic
4.6
7.4
24
53
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
13.5
7.4
12
9
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
7.4
73
346
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.8
7.4
44
160
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.4
157
989
SPAT1312
SPAT
General health counselling
1.6
7.4
263
1907
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
7.3
172
1118
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.0
7.3
22
45
Z29.0
ICD-10 Finland
Isolation
+∞
7.3
7
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
7.3
57
243
J05AB01
ATC
aciclovir; systemic
1.7
7.2
153
966
N30.9
ICD-10 Finland
Cystitis, unspecified
2.5
7.2
56
236
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.5
7.2
54
225
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.5
7.2
24
55
S06.0
ICD-10 Finland
Concussion
2.1
7.2
83
423
M13.9
ICD-10 Finland
Arthritis, unspecified
2.4
7.2
60
265
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.4
7.2
59
257
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.5
7.2
31
90
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
30.3
7.2
9
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
30.3
7.2
9
*
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
30.3
7.2
9
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.7
7.2
46
175
Z20.1
ICD-10 Finland
Contact with and exposure to tuberculosis
20.2
7.1
10
5
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.6
7.1
30
85
N03AX12
ATC
gabapentin; oral
1.9
7.1
111
633
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
7.1
64
292
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.7
7.1
19
34
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
7.1
166
1076
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
7.1
84
433
WW200
NOMESCO Finland
Immunization
3.9
7.0
27
71
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
7.0
66
309
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
6.4
7.0
17
27
L30.3
ICD-10 Finland
Infective dermatitis
3.4
6.9
32
98
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
6.9
57
247
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.0
6.9
26
67
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
6.9
77
387
M05BA04
ATC
alendronic acid; oral
2.5
6.9
54
228
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.4
6.8
14
17
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
6.8
6.8
16
24
N06AX16
ATC
venlafaxine; oral
1.8
6.8
112
649
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
11.0
6.8
12
11
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
9.4
6.8
13
14
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
40.4
6.8
8
*
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
40.4
6.8
8
*
WX402
NOMESCO Finland
General anaesthesia
1.8
6.7
123
741
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
6.6
25
65
H53.2
ICD-10 Finland
Diplopia
3.9
6.6
25
65
N05BE01
ATC
buspirone; oral
3.4
6.6
30
91
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.6
226
1616
SPAT1283
SPAT
Restricted health certificate
1.6
6.6
169
1121
SPAT1301
SPAT
No procedures
1.5
6.6
236
1705
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
8.8
6.6
13
15
R06AE07
ATC
cetirizine; oral
1.5
6.6
328
2546
A05AA02
ATC
ursodeoxycholic acid; oral
4.9
6.6
20
42
N03AG01
ATC
valproic acid; systemic, rectal
2.4
6.5
55
243
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
6.5
358
2835
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
5.1
6.5
19
38
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.7
6.5
42
161
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
6.5
86
464
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
6.5
28
82
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.3
6.5
22
52
JN4BD
NOMESCO Finland
Extensive body CT
2.1
6.4
74
378
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
6.4
57
258
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
6.4
23
57
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.5
6.4
14
19
T74.1
ICD-10 Finland
Physical abuse
3.7
6.4
26
72
S10
ICPC
Boil/carbuncle
2.4
6.4
51
218
WW500
NOMESCO Finland
Blood transfusion
3.2
6.4
31
99
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.9
6.4
37
132
A10AE04
ATC
insulin glargine; parenteral
2.1
6.4
73
370
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.5
6.4
21
48
N18.0
ICD-10 Finland
End-stage renal disease
6.6
6.4
15
23
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.2
6.3
13
16
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.6
6.3
17
31
B03XA02
ATC
darbepoetin alfa; parenteral
5.6
6.3
17
31
I50.0
ICD-10 Finland
Congestive heart failure
2.5
6.3
48
202
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
6.3
106
620
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
18.2
6.3
9
5
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
6.3
47
194
Z22.4
ICD-10 Finland
Carrier of infections with a predominantly sexual mode of transmission
+∞
6.3
6
*
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
26.9
6.2
8
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
26.9
6.2
8
*
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
6.2
127
792
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.1
6.2
32
107
WZC30
NOMESCO Finland
Teaching
1.9
6.2
95
539
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.0
6.2
33
113
C07AB07
ATC
bisoprolol; oral
1.5
6.2
283
2151
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
6.2
89
492
J01MA01
ATC
ofloxacin; systemic
2.1
6.2
63
306
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.7
6.1
13
17
T90
ICPC
Diabetes non-insulin dependent
1.7
6.1
135
859
R03BB04
ATC
tiotropium bromide; inhalant
2.1
6.1
64
312
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
6.1
39
147
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
6.1
37
138
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
4.4
6.1
20
46
QDA10
NOMESCO Finland
Incision of skin of lower limb
8.7
6.1
12
14
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
6.1
57
266
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
6.8
6.0
14
21
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.0
69
352
N05BA02
ATC
chlordiazepoxide; systemic
3.7
6.0
24
66
GBB00
NOMESCO Finland
Tracheostomy
6.1
6.0
15
25
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
6.0
62
303
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
321
622
7.55
171.70
5.0
3.0
—
—
—
0
0
114
240
5.31
52.23
2.1
1.6
160.2
0.3
iu/ml
0.77
34
42
167
533
3.63
44.06
2.7
2.5
10.9
10.4
g/l
0.67
147
485
40
33
12.65
40.40
1.8
1.4
734200.0
1214110.0
iu/ml
—
9
5
541
3438
2.49
37.04
8.2
5.9
9.9
11.0
umol/l
2.49
517
3254
70
130
5.76
36.53
4.8
3.4
4.5
4.3
e9/l
0.31
70
130
538
3429
2.46
36.31
11.2
5.6
28.1
28.2
%
0.03
519
3214
71
135
5.63
36.14
5.1
3.6
59.2
57.6
%
0.40
71
135
64
112
6.08
35.51
3.9
2.5
15.2
16.1
%
0.60
29
59
77
164
5.05
34.51
2.5
1.6
—
—
—
0
0
527
3390
2.38
33.91
10.4
5.4
56.5
57.3
%
0.76
507
3190
50
71
7.41
33.78
2.4
2.0
89.1
90.0
%
0.39
50
71
142
490
3.26
32.60
5.2
3.4
1.2
1.2
mmol/l
2.67
131
425
590
4044
2.39
31.96
14.1
8.6
4.3
4.1
e9/l
1.36
540
3543
29
24
12.46
29.11
4.0
2.2
—
—
—
0
0
691
5189
2.54
28.84
12.7
7.1
78.2
76.5
u/l
0.42
654
4855
434
2697
2.20
28.64
7.6
4.7
34.3
36.0
g/l
5.76
400
2511
126
441
3.17
28.07
2.0
1.6
—
—
—
0
0
266
1369
2.35
27.55
3.6
2.4
13.4
6.6
e6/l
0.50
236
1210
354
2063
2.20
27.07
3.2
2.5
52.7
56.5
u/l
1.18
317
1932
72
179
4.29
26.61
4.0
2.8
—
—
—
0
0
176
762
2.64
26.39
10.1
5.9
1.1
1.0
mmol/l
0.48
169
710
444
2847
2.13
26.33
7.6
5.6
1.2
1.2
mmol/l
0.12
415
2578
473
3155
2.08
24.70
9.8
6.3
1.2
1.2
mmol/l
0.02
361
2676
379
2352
2.07
23.84
4.5
3.0
—
—
—
0
0
375
2338
2.05
23.10
4.4
3.2
32.8
30.1
u/l
1.15
355
2225
140
589
2.64
21.99
2.6
2.3
0.2
0.2
g/l
1.54
131
558
34
51
6.89
21.81
2.0
2.1
15.2
13.4
%
0.26
13
28
543
3918
2.01
21.58
6.8
4.5
6.8
6.6
mmol/l
0.77
505
3588
46
94
5.11
21.54
3.9
3.1
1.2
1.3
%
0.05
39
79
32
46
7.18
21.32
2.0
2.2
—
—
—
0
0
34
53
6.63
21.04
1.8
1.5
—
—
—
0
0
302
1817
2.01
19.89
3.8
2.9
0.4
0.4
e6/l
0.01
255
1352
415
2785
1.93
19.81
2.8
2.2
73.9
74.9
nmol/l
0.30
385
2521
289
1725
2.01
19.37
2.7
2.0
3.4
3.0
mg/l
1.18
258
1493
364
2383
1.90
18.34
4.9
3.4
40.2
37.9
ng/l
0.12
245
1488
179
911
2.21
18.18
3.5
2.4
2.3
2.4
g/l
1.19
161
844
644
5099
1.98
17.63
7.2
3.8
14.6
11.1
mm/h
5.62
606
4715
185
973
2.14
17.22
3.7
3.3
0.8
0.8
mmol/l
0.40
174
915
142
674
2.32
16.97
4.1
4.0
217.8
252.8
u/l
1.82
134
635
23
31
7.59
16.17
2.5
2.4
828.0
646.9
u/ml
0.25
23
31
164
846
2.15
15.95
3.5
2.4
22.4
23.0
%
0.19
143
723
184
999
2.06
15.62
3.5
2.4
12.0
13.4
umol/l
1.62
167
926
295
1885
1.85
15.45
5.7
3.7
0.0
0.0
estimate
1.08
164
647
600
4737
1.84
15.35
6.6
4.2
5174.4
2175.5
e6/l
0.27
12
62
19
22
8.80
15.05
3.6
5.7
—
—
—
0
0
92
378
2.60
14.99
6.3
3.3
1.8
1.8
mmol/l
0.00
69
276
17
17
10.18
14.95
2.7
2.4
—
—
—
0
0
134
654
2.24
14.90
2.4
2.0
352.8
380.8
nmol/l
0.83
123
597
14
11
12.92
14.28
1.3
1.2
—
—
—
0
0
65
239
2.86
13.11
2.3
1.6
0.2
0.2
g/l
0.43
60
227
86
365
2.50
13.08
2.2
1.4
—
—
—
0
0
50
159
3.27
12.93
1.6
3.4
47.6
32.0
mg/l
1.31
36
124
50
159
3.27
12.93
1.6
3.4
58.4
95.8
mg/l
0.42
35
124
464
3516
1.68
12.56
6.6
4.7
0.0
0.0
estimate
0.50
167
654
463
3519
1.67
12.29
5.1
3.4
0.0
0.0
estimate
0.50
161
656
43
130
3.43
12.04
1.7
1.4
—
—
—
0
0
175
1017
1.90
11.95
2.3
1.8
—
—
—
0
0
465
3559
1.65
11.84
5.2
3.5
0.0
0.0
estimate
0.00
163
633
63
241
2.74
11.80
2.8
2.0
—
—
—
0
0
65
253
2.69
11.78
2.4
1.6
1.2
1.2
g/l
0.10
60
239
98
466
2.24
11.52
2.3
2.5
65.8
66.9
g/l
0.70
91
425
446
3423
1.61
10.89
4.0
2.8
127.3
102.2
ug/l
1.24
412
3196
313
2203
1.65
10.84
4.2
3.2
2.3
2.3
mmol/l
1.79
279
1953
250
1661
1.71
10.77
3.6
2.6
351.4
5890.7
umol/l
5.46
219
1453
43
140
3.18
10.72
3.6
2.3
121.8
131.3
g/l
1.77
37
108
798
7180
2.20
10.71
28.6
12.5
22.3
22.4
mg/l
0.02
710
5590
162
951
1.86
10.64
2.7
1.7
1.4
1.4
%
0.13
143
860
26
60
4.43
10.57
5.5
3.4
—
—
—
0
0
591
4883
1.64
10.46
4.7
3.0
47.8
42.0
u/l
0.64
551
4615
14
6
23.68
10.26
3.1
2.0
—
—
—
0
0
355
2608
1.61
10.19
2.0
1.9
94.5
96.1
pmol/l
0.31
200
1374
24
55
4.46
9.84
1.9
2.2
2442.1
478.2
e6/l
0.54
17
46
23
51
4.60
9.82
2.0
2.2
0.2
0.2
e9/l
0.65
17
45
241
1625
1.67
9.67
3.4
3.0
2792.6
1297.3
ng/l
1.63
200
1345
46
166
2.87
9.63
1.4
1.3
—
—
—
0
0
14
8
17.76
9.42
3.1
1.9
—
—
—
0
0
744
6602
1.82
9.40
23.8
11.1
87.4
86.4
ml/min/173m2
0.51
654
5307
176
1103
1.74
9.20
2.2
1.6
1343.2
1194.4
nmol/l
0.98
127
837
65
286
2.37
9.15
1.4
1.4
—
—
—
0
0
22
50
4.49
9.12
2.2
1.4
—
—
—
0
0
363
2734
1.56
9.07
5.8
3.6
—
—
—
0
0
19
39
4.96
8.87
2.2
1.5
—
—
—
0
0
46
174
2.73
8.84
1.8
1.5
—
—
—
0
0
35
115
3.13
8.63
2.0
1.6
—
—
—
0
0
27
75
3.68
8.61
2.0
1.5
—
—
—
0
0
40
143
2.88
8.53
6.1
6.1
2168.0
339.3
iu/ml
—
6
21
17
33
5.23
8.43
10.8
5.2
97.9
31.5
u/ml
—
9
6
785
7146
1.91
8.27
26.5
13.8
139.1
139.6
mmol/l
6.79
763
6955
43
164
2.71
8.15
1.2
1.2
—
—
—
0
0
786
7165
1.91
8.14
27.0
13.9
3.9
3.9
mmol/l
0.28
765
6957
120
697
1.84
8.05
16.0
21.8
1.2
1.2
inr
0.22
17
105
428
3415
1.49
7.78
5.8
4.0
—
—
—
0
0
25
71
3.59
7.74
2.3
1.7
69.8
61.7
%
0.45
18
51
22
57
3.93
7.74
5.2
3.1
65.7
55.7
%
1.06
15
41
231
1622
1.58
7.61
1.9
1.7
1.7
1.1
mg/l
0.56
167
1236
198
1343
1.61
7.54
2.0
1.6
480.9
39295574.1
pmol/l
2.02
155
1135
642
5601
1.54
7.33
5.0
4.0
14.8
14.6
pmol/l
0.83
590
5129
26
79
3.36
7.29
2.1
1.5
30.8
32.5
pg
0.75
26
79
271
1992
1.52
7.20
8.9
3.2
7.2
7.8
mmol/l
1.08
223
1683
54
244
2.29
7.19
1.9
1.9
—
—
—
0
0
32
112
2.93
7.12
1.1
1.1
—
—
—
0
0
21
56
3.82
7.11
2.0
2.0
4996.9
820.2
e6/l
0.45
11
23
41
167
2.53
6.85
1.9
1.5
—
—
—
0
0
40
161
2.56
6.85
1.3
1.2
297.6
238.8
u/ml
0.65
23
100
11
17
6.54
6.79
1.3
1.1
—
—
—
0
0
29
99
3.00
6.75
2.1
1.4
—
—
—
0
0
15
32
4.75
6.70
2.4
1.5
—
—
—
0
0
15
32
4.75
6.70
2.4
1.5
—
—
—
0
0
107
636
1.78
6.64
3.1
2.3
26.8
110.1
u/l
0.56
95
531
28
95
3.01
6.59
1.9
1.5
—
—
—
0
0
27
90
3.06
6.54
2.0
1.4
—
—
—
0
0
35
135
2.66
6.53
1.7
1.7
—
—
—
0
0
39
159
2.52
6.52
2.1
1.4
—
—
—
0
0
83
459
1.89
6.49
5.1
4.0
93.0
80.0
ng/l
0.75
71
411
124
781
1.68
6.26
4.2
2.6
7.0
8.1
umol/l
0.28
101
662
152
1010
1.61
6.22
3.3
2.7
3.8
2.7
e6/l
0.61
98
535
35
139
2.58
6.18
1.6
1.4
108.3
107.7
u/ml
—
9
26
26
89
2.98
6.04
1.3
1.3
—
—
—
0
0
254
1905
1.47
5.93
2.6
2.1
188.2
212.0
u/l
0.18
233
1791
21
64
3.34
5.89
3.3
2.1
—
—
—
0
0
95
566
1.76
5.85
4.2
3.7
1.6
1.9
mmol/l
0.27
77
456
47
220
2.20
5.80
1.3
1.8
—
—
—
0
0
47
220
2.20
5.80
1.3
1.8
7.2
7.3
g/l
0.25
34
173
47
220
2.20
5.80
1.3
1.8
3.7
3.8
g/l
0.24
33
165
45
207
2.24
5.79
1.2
1.8
2.8
3.1
g/l
1.54
33
168
95
568
1.75
5.78
4.2
3.7
5.9
5.8
kpa
0.37
90
554
39
169
2.37
5.75
1.4
1.5
456.5
416.2
mg/l
0.35
34
160
685
6171
1.50
5.72
30.0
15.2
13.9
13.6
%
5.88
679
6049
194
1388
1.51
5.69
2.6
2.2
—
—
—
0
0
236
1759
1.47
5.65
1.3
1.3
1.8
1.6
u/ml
0.08
75
466
47
223
2.17
5.61
2.0
1.7
—
—
—
0
0
32
129
2.54
5.50
2.6
3.2
31.4
31.2
umol/l
0.02
25
112
143
965
1.58
5.46
2.8
2.2
31.2
29.7
s
1.89
137
936
36
155
2.38
5.40
1.5
1.7
18.6
11.5
e6/l
0.32
25
125
9
8
11.35
5.30
1.2
3.1
—
—
—
0
0
22
74
3.02
5.29
1.2
1.2
—
—
—
0
0
56
293
1.97
5.19
1.5
2.2
41.8
39.3
u/l
0.39
49
266
174
1240
1.50
5.17
1.4
1.3
66.4
30.0
iu/ml
1.94
63
390
82
490
1.74
5.01
2.3
2.3
30.8
16.8
au/ml
—
7
27
30
123
2.49
5.00
1.9
1.4
—
—
—
0
0
27
107
2.57
4.83
2.0
1.4
—
—
—
0
0
11
24
4.63
4.79
2.5
2.3
—
—
—
0
0
42
204
2.11
4.77
1.3
1.8
11.2
10.5
g/l
0.33
35
180
13
33
3.98
4.72
1.1
1.3
—
—
—
0
0
21
74
2.88
4.68
1.0
1.1
—
—
—
0
0
199
1487
1.44
4.60
1.6
1.5
20.5
20.9
nmol/l
0.14
173
1286
27
110
2.50
4.58
1.7
1.4
—
—
—
0
0
11
25
4.44
4.57
1.0
1.2
—
—
—
0
0
32
142
2.30
4.52
3.4
1.7
11055.1
15600.2
e6/l
0.35
18
106
802
7571
1.67
4.52
17.6
9.4
27.1
25.7
u/l
1.11
775
7320
76
459
1.72
4.49
3.4
3.4
4.3
4.6
pmol/l
1.34
68
403
718
6627
1.45
4.41
5.9
4.7
1.8
2.0
mu/l
0.43
663
6122
11
26
4.27
4.36
2.3
1.5
25.9
29.4
umol/l
0.51
11
26
171
1258
1.45
4.28
2.4
2.0
—
—
—
0
0
107
715
1.57
4.25
2.1
1.7
—
—
—
0
0
13
36
3.65
4.21
1.3
1.1
—
—
—
0
0
20
73
2.78
4.20
1.6
1.7
—
—
—
0
0
39
194
2.06
4.19
1.5
1.4
—
—
—
0
0
8
10
8.06
4.06
1.9
1.4
—
—
—
0
0
10
24
4.20
3.89
1.4
2.9
—
—
—
0
0
106
722
1.53
3.88
2.2
1.8
—
—
—
0
0
48
265
1.86
3.85
1.5
1.3
7.7
9.1
u/l
0.43
43
212
14
44
3.22
3.79
1.5
1.2
—
—
—
0
0
38
195
1.99
3.78
1.4
2.0
0.3
1.3
g/l
1.85
31
175
40
210
1.95
3.73
1.3
1.2
—
—
—
0
0
40
211
1.94
3.69
1.3
1.2
—
—
—
0
0
16
56
2.89
3.64
1.8
1.6
—
—
—
0
0
75
480
1.61
3.59
2.4
2.2
4846.7
5975.9
u/l
0.14
32
201
42
232
1.85
3.39
2.9
3.3
58.5
1677.1
u/ml
1.33
34
204
153
1150
1.40
3.38
3.0
2.8
2.5
2.4
mmol/l
0.88
129
1009
9
18
5.04
3.37
1.3
1.1
—
—
—
0
0
9
18
5.04
3.37
1.3
1.1
99.3
98.6
%
—
9
18
576
5225
1.30
3.29
3.8
3.4
—
—
—
0
0
70
452
1.60
3.25
1.6
1.5
—
—
—
0
0
36
192
1.91
3.24
2.1
2.2
270.5
237.2
ug/l
0.13
30
181
44
252
1.79
3.18
1.8
1.8
—
—
—
0
0
45
743
0.58
3.14
1.6
1.6
—
—
—
0
0
11
34
3.26
3.06
1.3
1.1
964.3
1418.9
miu/ml
1.02
11
34
36
196
1.87
3.06
1.4
1.2
6.2
2.9
u/ml
—
6
27
34
182
1.90
3.04
1.3
1.8
36.9
37.9
g/l
0.33
29
162
5
5
10.05
2.98
3.4
1.6
2.2
2.9
mg/l
—
5
5
36
198
1.85
2.98
1.4
1.2
20.1
9.9
u/ml
—
6
38
11
35
3.17
2.93
1.4
1.3
—
—
—
0
0
10
30
3.36
2.91
1.3
1.3
—
—
—
0
0
14
52
2.72
2.90
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
164
1.92
2.88
3.7
3.9
0.3
0.3
u/ml
0.02
21
92
15
58
2.61
2.88
1.8
1.4
6132.6
304524.2
e6/l
—
8
40
16
64
2.53
2.88
1.5
1.3
—
—
—
0
0
213
1729
1.31
2.82
1.8
1.6
1.4
1.4
mmol/l
0.08
174
1482
34
187
1.85
2.82
1.5
1.4
243.3
297.4
ug/g
0.69
19
96
11
36
3.08
2.81
1.4
1.7
—
—
—
0
0
11
36
3.08
2.81
1.4
1.7
—
—
—
0
0
11
36
3.08
2.81
1.4
1.7
—
—
—
0
0
11
36
3.08
2.81
1.4
1.7
—
—
—
0
0
16
65
2.49
2.80
1.5
1.3
—
—
—
0
0
27
138
1.99
2.77
1.8
1.4
—
—
—
0
0
27
138
1.99
2.77
1.8
1.4
—
—
—
0
0
12
42
2.88
2.76
1.3
1.0
—
—
—
0
0
6
10
6.03
2.70
1.0
1.1
—
—
—
0
0
6
10
6.03
2.70
1.0
1.1
—
—
—
0
0
221
1823
1.28
2.57
6.4
4.1
27.1
11.0
mg/mmol
1.46
144
1160
8
20
4.03
2.57
1.0
1.0
—
—
—
0
0
29
157
1.88
2.55
1.6
1.4
—
—
—
0
0
6
11
5.48
2.54
1.3
1.6
—
—
—
0
0
57
374
1.56
2.52
2.0
1.6
—
—
—
0
0
82
584
1.45
2.47
4.4
4.3
4.2
34.0
ug/l
1.36
64
473
150
1182
1.32
2.45
1.4
1.3
25.9
12.6
u/ml
1.04
71
465
710
6715
1.30
2.41
4.7
4.0
5.9
5.8
mmol/l
0.65
645
6168
63
429
1.50
2.37
1.5
1.4
—
—
—
0
0
63
429
1.50
2.37
1.5
1.4
—
—
—
0
0
5
8
6.28
2.37
3.8
12.7
0.3
0.3
umol/l
—
5
8
5
8
6.28
2.37
1.4
1.0
—
—
—
0
0
8
22
3.66
2.36
2.0
2.0
74.3
58.1
ug/l
—
8
22
63
430
1.50
2.35
1.5
1.4
—
—
—
0
0
63
431
1.50
2.33
1.5
1.4
—
—
—
0
0
21
105
2.02
2.32
1.3
1.1
—
—
—
0
0
205
1696
1.27
2.32
3.2
2.1
—
—
—
0
0
10
35
2.88
2.31
3.0
1.7
—
—
—
0
0
101
1324
0.73
2.29
3.5
4.2
22.0
21.5
%
0.13
43
602
139
1095
1.32
2.28
2.8
2.5
0.9
0.9
e6/l
0.05
83
615
663
6236
1.26
2.24
6.4
5.2
39.6
39.0
mmol/mol
0.77
608
5830
82
596
1.41
2.23
1.3
1.2
57.7
145.7
iu/ml
4.03
30
238
14
60
2.35
2.22
1.1
1.0
—
—
—
0
0
75
540
1.43
2.15
8.3
6.5
1.4
1.4
mmol/l
0.10
68
517
32
190
1.71
2.12
1.2
1.1
—
—
—
0
0
21
109
1.95
2.12
1.0
1.1
—
—
—
0
0
25
138
1.84
2.11
1.4
1.4
18.2
19.5
u/l
0.07
20
117
9
31
2.92
2.07
1.2
1.0
187.1
199.4
iu/ml
—
9
31
87
648
1.38
2.06
2.1
1.7
—
—
—
0
0
20
103
1.96
2.06
1.8
1.4
—
—
—
0
0
8
26
3.10
2.01
1.4
1.9
—
—
—
0
0
8
26
3.10
2.01
1.4
1.9
—
—
—
0
0
15
70
2.16
1.99
1.3
1.1
—
—
—
0
0
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
47
315
1.52
1.95
1.1
1.3
183.1
239.1
miu/ml
0.53
21
157
8
27
2.98
1.94
1.5
1.9
—
—
—
0
0
14
65
2.17
1.88
1.7
1.7
—
—
—
0
0
175
1458
1.25
1.86
1.7
1.5
—
—
—
0
0
14
66
2.14
1.82
1.1
1.4
49.8
35.3
nmol/l
0.56
14
58
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
60
429
1.43
1.82
1.3
1.4
20.1
24.1
iu/l
0.51
53
360
87
665
1.34
1.78
7.8
8.0
1.2
1.1
mmol/l
0.09
73
524
50
348
1.46
1.75
2.0
1.6
—
—
—
0
0
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
12
55
2.20
1.68
1.2
1.1
—
—
—
0
0
7
25
2.81
1.65
1.3
1.0
—
—
—
0
0
5
14
3.59
1.61
1.0
1.3
—
—
—
0
0
5
14
3.59
1.61
2.4
1.4
—
—
—
0
0
68
509
1.36
1.61
3.2
2.4
59.9
70.7
ml/min/173m2
1.20
42
203
13
63
2.08
1.60
1.2
1.2
—
—
—
0
0
13
63
2.08
1.60
1.7
1.6
—
—
—
0
0
13
63
2.08
1.60
1.7
1.6
—
—
—
0
0
13
63
2.08
1.60
1.7
1.6
—
—
—
0
0
13
63
2.08
1.60
1.2
1.2
—
—
—
0
0
8
32
2.51
1.60
1.5
1.6
—
—
—
0
0
8
32
2.51
1.60
1.5
1.6
—
—
—
0
0
14
70
2.02
1.60
1.1
2.0
20.6
22.6
nmol/l
0.42
14
65
59
432
1.39
1.59
1.1
1.0
—
—
—
0
0
142
1178
1.24
1.57
3.5
3.5
76.3
394.0
ng/l
2.35
83
852
13
64
2.05
1.54
1.2
1.2
—
—
—
0
0
13
64
2.05
1.54
1.2
1.2
—
—
—
0
0
13
64
2.05
1.54
1.2
1.2
—
—
—
0
0
10
44
2.29
1.53
1.8
2.5
—
—
—
0
0
29
185
1.59
1.53
1.8
1.7
34.6
39.3
nmol/l
0.78
29
179
23
368
0.61
1.52
1.6
1.6
—
—
—
0
0
7
27
2.60
1.51
1.1
1.3
—
—
—
0
0
11
51
2.17
1.51
1.2
1.5
—
—
—
0
0
27
170
1.61
1.50
2.3
2.0
4.2
4.5
umol/l
0.19
22
126
104
837
1.28
1.49
2.4
1.8
—
—
—
0
0
13
65
2.01
1.49
1.8
1.3
1.2
0.4
u/ml
—
8
28
194
1674
1.20
1.47
2.0
1.6
—
—
—
0
0
35
236
1.50
1.46
3.4
6.7
1.5
1.6
%
0.31
30
222
5
16
3.14
1.44
1.6
1.3
—
—
—
0
0
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
827
8090
1.37
1.43
38.5
18.5
131.0
135.1
g/l
11.89
816
7985
16
275
0.57
1.41
1.6
1.5
—
—
—
0
0
76
959
0.77
1.36
2.7
2.9
0.9
0.7
ug/l
0.53
51
603
84
667
1.29
1.35
7.9
7.9
5.3
5.1
kpa
1.37
79
633
84
667
1.29
1.35
7.8
7.9
11.1
12.4
kpa
2.04
79
637
13
68
1.93
1.34
5.5
1.8
—
—
—
0
0
17
98
1.75
1.31
3.1
2.6
62.4
48.4
u/ml
0.08
17
86
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
9
44
2.06
1.27
1.0
1.0
279.8
290.8
mg/l
—
9
39
58
442
1.33
1.26
2.4
2.2
11.8
12.5
nmol/l
0.28
52
388
65
504
1.31
1.26
1.6
1.4
—
—
—
0
0
19
115
1.67
1.25
1.0
1.2
68.2
62.2
iu/ml
—
5
27
93
757
1.26
1.24
1.6
1.5
—
—
—
0
0
6
25
2.41
1.24
1.8
1.3
—
—
—
0
0
6
25
2.41
1.24
1.8
1.3
—
—
—
0
0
23
147
1.58
1.24
4.6
3.8
46.5
22.9
mg/l
1.06
17
90
41
297
1.40
1.22
1.4
1.5
—
—
—
0
0
8
39
2.06
1.15
2.5
2.9
—
—
—
0
0
7
30
2.34
1.12
1.7
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
40
2.01
1.12
1.4
1.1
—
—
—
0
0
7
31
2.27
1.10
1.7
1.3
—
—
—
0
0
14
81
1.74
1.09
1.1
1.1
—
—
—
0
0
21
137
1.55
1.06
1.2
1.2
3.9
7.0
u/ml
0.56
12
60
5
22
2.28
1.03
2.0
2.7
14.0
15.2
umol/l
—
5
22
10
53
1.90
1.01
1.1
1.3
—
—
—
0
0
12
68
1.78
1.01
4.8
1.6
—
—
—
0
0
20
131
1.54
1.00
1.2
1.2
1.2
4.7
u/ml
—
6
43
95
797
1.22
0.99
4.1
4.1
33.8
31.6
%
0.97
69
552
13
77
1.70
0.95
1.1
1.1
—
—
—
0
0
6
28
2.15
0.91
2.2
3.0
234.8
200.4
u/l
—
6
28
6
29
2.08
0.89
1.2
1.3
—
—
—
0
0
19
127
1.51
0.89
1.1
1.1
—
11.2
—
0
10
23
323
0.70
0.89
1.9
2.0
—
—
—
0
0
8
42
1.91
0.88
1.1
1.6
2.0
2.0
u/field
—
8
31
22
158
1.40
0.75
1.4
1.2
—
—
—
0
0
22
158
1.40
0.75
3.8
2.4
178.3
136.3
ug/min
0.13
16
99
174
1576
1.13
0.73
6.0
3.8
1.0
1.0
kg/l
0.40
25
226
10
60
1.67
0.72
1.2
1.2
1.4
1.5
nmol/l
—
10
53
13
84
1.56
0.72
1.6
1.4
—
—
—
0
0
13
84
1.56
0.72
1.6
1.4
—
—
—
0
0
13
84
1.56
0.72
1.6
1.4
—
—
—
0
0
9
58
1.56
0.70
2.1
1.7
10.6
11.5
umol/l
—
9
53
13
85
1.54
0.69
1.6
1.4
—
—
—
0
0
13
85
1.54
0.69
1.6
1.4
—
—
—
0
0
13
85
1.54
0.69
1.6
1.4
—
—
—
0
0
10
61
1.65
0.68
2.9
1.3
—
—
—
0
0
19
137
1.40
0.65
1.5
1.3
—
—
—
0
0
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
27
209
1.30
0.61
2.8
1.8
3.2
5.3
iu/l
1.32
19
78
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
179
1650
1.11
0.57
3.6
4.7
1.8
2.4
ug/l
1.10
150
1474
53
453
1.18
0.52
1.4
1.4
—
—
—
0
0
9
64
1.41
0.51
1.3
1.1
—
—
—
0
0
25
311
0.80
0.48
2.2
1.7
—
—
—
0
0
7
49
1.43
0.46
1.3
2.7
—
—
—
0
0
677
6895
0.92
0.45
4.5
4.0
4.5
4.7
mmol/l
6.27
619
6449
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
0.1
—
0
9
11
79
1.40
0.41
2.6
2.8
104.9
105.3
mmol/l
0.08
11
79
11
79
1.40
0.41
2.6
2.8
4.0
4.1
mmol/l
0.31
11
79
23
186
1.24
0.40
1.5
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
351.2
—
0
11
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
675
6861
0.93
0.38
4.4
3.9
1.4
1.5
mmol/l
3.89
616
6384
6
44
1.37
0.34
1.5
2.2
—
—
—
0
0
649
6595
0.94
0.34
4.0
3.6
1.3
1.3
mmol/l
0.73
588
6114
15
122
1.23
0.27
1.1
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
0.7
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
31
283
1.10
0.16
3.1
2.6
0.6
0.7
%
0.39
31
274
685
6808
1.03
0.11
22.7
13.5
39.2
39.8
%
1.26
461
5234
75
776
0.96
0.09
7.6
6.4
—
—
—
0
0
6
72
0.83
0.07
7.3
1.6
—
—
—
0
0
698
7001
0.99
0.04
4.7
4.3
2.6
2.8
mmol/l
4.73
634
6508
16
150
1.07
0.04
1.8
1.9
—
—
—
0
0
19
181
1.05
0.03
1.1
1.1
0.2
1.4
u/ml
—
9
73
30
307
0.98
0.01
1.5
1.4
—
—
—
0
0
19
196
0.97
0.00
1.2
1.2
1.9
2.8
ug/l
1.16
19
178
12
124
0.97
0.00
1.0
1.0
1.6
1.7
u/ml
—
6
55
50
496
1.01
0.00
2.6
2.5
4.8
5.7
ug/l
0.26
43
440
19
189
1.01
0.00
1.3
1.1
—
—
—
0
0
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
54
0.93
0.00
2.6
1.6
0.8
1.0
g/l
—
5
54
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
7
70
1.00
0.00
1.7
2.1
—
23.1
—
0
19
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_CARRIER_INFECTIOUS_DISEA – Carrier of infectious disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).